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Neurological and neuropathological sequelae of correction of chronic
hyponatremia. The effect of correction of chronic hyponatremia at
different rates was studied in 91 rats maintained at a plasma [Nat] of
112 1 mmollliter for 19 1 days. Hyponatremia was corrected into
normal ranges (140 to 145 mmol/liter) using three different methods.
Rats corrected by water restriction achieved normal plasma [Na'4i by
2.1 0,2 day and had a maximal (4 hi') correction rate of 1.0 0.1
mmol/1iter hr; rats corrected by water diuresis achieved normal plasma
[Na'4i by 1.6 0.1 day and had a maximal correction rate of 2.8 0.2
mmol/liter hr; rats corrected by hypertonic saline infusion achieved
normal plasma [Na'] by 5.4 0.3 hr and had a maximal correction rate
of 5.7 0.4 mmollliter hr. A fourth control group was not corrected.
No demyelinative lesions were found in the brains from the uncorrected
rats, whereas the occurrence of such lesions in the brains of the
corrected rats was highly correlated with the maximal rate of increase
in plasma [Na'4'] (r = 0.68, P < 0.001), and to a lesser degree with the
magnitude of the increase in plasma [Nat] over the first 24 hours of
correction (r 0.41, P <0.001). Brain myelinolysis was first observed
in animals whose maximal (4 hi') rate of correction exceeded 1.75
mmol/liter hr, and the incidence of demyelination increased progres-
sively in rats with more rapid rates of correction. Similarly, myelinol-
ysis was first observed in rats whose magnitude of correction at 24
hours exceeded 16 mmol/liter and also increased in rats with larger 24
hour magnitudes of correction. Analysis of the incidence of myelinol-
ysis using both of these correction parameters together indicated that
demyelination did not occur in rats whose maximal rate of increase in
plasma [Na'4'] did not exceed 4 mmol/liter hr and whose absolute
increase in plasma [NaI did not exceed 25 mmol/liter in the first 24
hours; for all rats who exceeded either one of these two limits the
incidence of demyelinative lesions was 64%. Our results suggest that
the maximal rate as well as the magnitude of correction of plasma [Na" I
represent significant risk factors for the development of brain myelinol-
ysis after correction of experimental hypoosmolality in chronically
hyponatremic rats.
Both hyponatremia and rapid correction of hyponatremia can
cause neurological dysfunction and neuropathological damage
in humans [1—4]. However controversy still exists with regard
to the relative degree to which each of these factors contributes
to the morbidity and mortality associated with hyponatremia in
human patients [4—8]. In particular, there is disagreement about
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the relation between correction of existing hyponatremia and
the production of pontine and extrapontine brain myelinolysis.
Although this disorder has been reported relatively infre-
quently, its neurological sequelae can be devastating to affected
patients [9, 10]. Recent clinical studies have provided substan-
tial evidence supporting both the rate and the magnitude of
correction of hyponatremia as important determinants of clini-
cal outcomes following correction of hyponatremia [3—5, 81, but
acceptable limits for both parameters remain uncertain at the
present time [7].
The rarity of this disorder in combination with the potential
gravity of its consequences for individual patients makes fur-
ther study via controlled clinical trials problematical. For this
reason, many animal studies have attempted to address this
issue. These studies have uniformly documented that demyeli-
native lesions can be produced by correction of experimentally-
induced hyponatremia in multiple species [11—161. However,
the ease with which demyelination has been produced following
correction of hyponatremia in animals stands in marked con-
trast to the relative rarity of reports of this disorder in humans.
This discrepancy between the clinical and experimental expe-
riences raises questions as to the relevance of animal studies of
hyponatremia to human disease.
Review of the reported animal experiments to date reveals
three common characteristics that to varying degrees poten-
tially interfere with interpretation of their results: 1) most
previous studies employed relatively short periods of acute
sustained hyponatremia, generally from one to four days; 2)
many previous studies experienced high mortality (as much as
30 to 50% in some studies) as a result of the acutely-induced
hyponatremia even before correction, thus complicating an
assessment of whether the correction or the preexisting hy-
ponatremia itself contributed more to the morbidity and mor-
tality following the correction; 3) no previous studies carefully
monitored the progress of the induced corrections with suffi-
cient frequency to allow accurate assessment of maximal rates
of increase of plasma Na concentration ([Na'4]), and many
utilized methods that likely produced rates of correction of
hyponatremia in excess of those generally encountered in
clinical experience.
The experiments reported here represent an attempt to study
the relation between the rate of correction of plasma [Na''] and
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the development of brain myelinolysis using a newly described
model of chronic hyponatremia in rats associated with negligi-
ble morbidity and mortality [171. By inducing corrections of
hyponatremia via different methods while closely monitoring
acute and chronic changes in plasma [NaI, we were able to
more closely analyze in individual rats the relation between the
rate of correction of plasma [Nat], as well as several other
parameters related to correction of hyponatremia, and the
subsequent development of demyelinative brain lesions result-
ing from myelinolysis.
Methods
Animals and maintenance
Male albino rats of the Sprague-Dawley strain (Zivic-Miller,
Allison Park, Pennsylvania, USA) weighing 275 to 325 g were
used for all studies. They were housed individually in stainless
steel wire mesh cages in a temperature-controlled room (22°C)
with lights on from 7 a.m. to 7 p.m. All rats were given pelleted
rat chow (Wayne Labs, Chicago, Illinois, USA) and tap water
ad libitum until initiation of the protocol used to induce and
maintain hyponatremia.
Induction of hyponatremia
Hyponatremia was induced and maintained using methods
described recently [17]. Briefly, rats were first acclimated to a
rodent liquid diet formula supplying 1.0 kcal/ml (AIN-76; Bio-
serv, Frenchtown, New Jersey, USA). After two to three days,
osmotic minipumps (Alzet model 2002; Alza, Palo Alto, Cali-
fornia, USA) containing I -deamino-[8-D-argininel-vasopressin
(DDAVP; Rorer Pharmaceuticals, Fort Washington, Pennsyl-
vania, USA) at a concentration of 10 g/ml were implanted
subcutaneously under methoxyflurane anesthesia. This resulted
in a continuous DDAVP infusion rate of 5 ng/hr. On the day of
minipump insertion the rats were given 70 ml of AIN-76 at the
regular dilution, then 40 ml of a more concentrated AIN-76
mixture supplying 1.9 kcal/ml each day thereafter [17]. Tap
water was withheld during the DDAVP infusions. The osmotic
minipumps were replaced at 13 day intervals to maintain a
continuous DDAVP infusion. All animals were kept hypona-
tremic for two to three weeks (mean duration of hyponatremia
= 19.4 0.3 days) prior to correction of the chronic hypona-
tremia as described below.
Correction of hyponatremia.
Two days prior to correction of the hyponatremia all rats had
indwelling jugular venous catheters inserted using methods
previously described [18]. This enabled infusion of hypertonic
saline at a controlled rate, as well as frequent blood sampling
for measurement of plasma [Nat]. Blood samples consisted of
0.25 ml of whole blood which were immediately centrifuged
(3,000 x g for 10 mm at 4°C). Plasma [Nai was measured after
centrifugation via ion-specific electrodes (Beckman Electrolyte
2 Analyzer, Brea, California, USA). The red blood cells were
suspended in an equal volume of 140 mri NaCl and reinfused
into the same animals. Four separate groups of rats were
studied:
Group I—no correction (NC). Rats (N = 20) were not
corrected, but rather continued on liquid formula and DDAVP
infusions to maintain the hyponatremia until euthanasia. Plasma
[Na41 was measured daily for six to seven days at which time
the rats were euthanized for histological brain analysis.
Group Il—water restriction (WR). Rats (N = 23) continued
on DDAVP infusions, but the liquid formula was replaced with
pelleted chow and tap water ad libitum. Under these conditions
rats self-restrict ingested water to the amount required to
replace daily losses [191. Plasma [Nat] was measured every
four hours for the first eight hours after the diet change, and
then daily thereafter for six to seven days.
Group 111—water diuresis (WD). The osmotic minipumps
were removed from rats (N = 26) under light inhalational
anesthesia with methoxyflurane, thereby stopping the DDAVP-
induced antidiuresis. Animals were switched from the liquid
diet to pelleted chow and tap water ad libitum. Plasma [Nai
was measured every two hours for the first eight hours after the
osmotic minipump removal, and then daily thereafter for six to
seven days.
Group I V—hypertonic saline (HS). Rats (N = 22) received a
continuous intravenous infusion of 2.0 M NaC1 at a rate of 1.0
mi/hr via syringe pumps (model A-99; Razel, Stamford, Con-
necticut, USA). Plasma [Nai was measured every two hours
during the infusion, and the infusion was stopped once plasma
[Nat] was 140 mmoi/iiter to avoid overcorrection of the
hyponatremia. The DDAVP infusions continued as before, but
the rats were switched to pelleted chow and tap water ad
libitum at the end of the hypertonic saline infusion to prevent
recurrence of hyponatremia after the correction. Plasma [Nat]
measurements continued every two hours until eight hours after
the start of the infusion, and then daily thereafter for six to
seven days.
Rats from all groups were maintained for six to seven days
following the correction of hyponatremia (including the uncor-
rected NC group) before euthanasia for neuropathological anal-
ysis. This interval following correction was selected to provide
sufficient time for demyelinative lesions to be detected histo-
logically [II]. During this period the rats were closely observed,
handled, weighed, and had water intakes measured daily.
However, rats were euthanized prematurely before six to seven
days if they appeared sufficiently impaired to make survival for
the full length of time unlikely. Criteria used for premature
euthanasia included loss of more than 25% of body weight,
seizure activity, paralysis of the hind limbs with impairment of
ambulation, or marked lethargy to the point of unresponsive-
ness to tactile stimuli. Lesser degrees of neurological dysfunc-
tion such as hyperirritability, inadequate grooming (as evi-
denced by ruffled dirty fur), and decreased spontaneous motor
activity were recorded, but were not considered indications for
euthanasia.
Neuropathological analysis
Rats were euthanized by decapitation after which the brains
were rapidly dissected and immersion fixed in 10% buffered
formaldehyde for at least 48 hours. Only rats surviving to the
point of euthanasia were included in this analysis; any rats
dying prematurely were excluded to avoid autolysis artifacts in
the interpretation of the brain histology. The brains were then
embedded in paraffin and sectioned transversely at three levels
through the brainstem and coronally at three levels through the
forebrain. Representative sections (20 to 25 j.tm) were stained
with hematoxylin-eosin for evaluation of neuronal density and
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Table 1. Summary of plasma [Na] changes, rates of correction, and neuropathology for each treatment group
Plasma [NaJ
mmol/liter
Correction rate
mmol/liter hr
Neuropathology
0
(None)
1 2
(Focal) (Diffuse)Start Finish Delta Max 0—24 hr O—48 hr
No correction (NC) 111 2 113 2 2 1 0 0 0 100% 0% 0%
N = 20 .—
0%
Water restriction (WR) 114 1 142 1 27 1 1.0 0.1 0.8 0.1 0.5 0.1 95% 0% 5%
N = 22 .—
5%
Water diuresis (WD) 110 2 143 1 33 2 2.8 02b 1.2 01h 0.7 01b 80% 8% 12%
N = 24 —
20%
Hypertonic saline (HS) 113 2 142 1 30 2 5.7 1.1 01b 0.6 0.1 10% 38% 52%N = 21 '—.----—-
90%
a P < 0.05, b P < 0.01 compared to WR
P < 0.01 compared to WD
Luxol fast blue for evaluation of myelin integrity. All sections
were interpreted by a neuropathologist (MM) without knowl-
edge of the treatment group of the animals. The presence of
brain pathology was graded according to the following scoring
system:
0 = no pathological lesions;
1 = focal demyelination (lesions detected in only one brain
region);
2 = diffuse demyelination (lesions detected in more than one
brain region, including bilateral lesions of the same region).
Statistical analysis
All results are reported as means SE. Statistical significance
for continuous functions was determined by one-way ANOVA
for comparison of multiple groups, with post-hoc comparisons
via Bonferroni protected t-tests for comparison of paired
groups, and for analysis of the frequency of neurological
findings in individual animals by chi-square analysis. Correla-
tion coefficients were calculated by the method of Pearson.
Two-group discriminant function analysis was performed using
the presence (neuropathological score = 1 or 2) or absence
(neuropathological score = 0) of demyelinative brain lesions as
the dependent variable (GBSTAT software, Dynamic Mi-
crosystems, Silver Spring, Maryland, USA).
Results
Results of the four treatment groups are summarized in Table
1. All rats began at levels of plasma [Na] that were not
statistically different from each other. The Group I (NC) rats
remained hyponatremic at equivalently low plasma [Na]
throughout the six to seven day period before euthanasia
(plasma [NaJ = 113 2 mmolfliter on the day of euthanasia).
In contrast, each of the three correction groups eventually
achieved plasma [Na] that were within normal ranges for rats
(defined for our laboratory as 140 to 145 mmol/liter). The total
magnitude of the final correction of the plasma [Nat] was
equivalent among the three corrected groups [although the total
magnitude of the correction was significantly higher for the
Group III (WD) rats than the Group II (WR) rats (P < 0.05),
neither of these two groups had significantly greater total
corrections than the Group IV (HS) rats]. However, the times
required to reach these normal ranges differed greatly among
the three correction groups. The Group II (WR) rats reached
normal levels after 2.1 0.2 day, the Group III (WD) rats after
1.6 0.1 day, and the Group IV (HS) rats after only 5.4 0.3
hr (P < 0.01 between each group). These differences in the rates
of correction among the treatment groups can be appreciated
graphically in Figure 1, which shows the sequentially-measured
plasma [Nat] of each group over the 48 hour period following
initiation of correction of the hyponatremia.
Small but different numbers of rats in each group either died
spontaneously or had to be euthanized because of weight loss or
impaired neurological function prior to six to seven days. In
Group I (NC) no animals died spontaneously or had to be
prematurely euthanized; in Group II (WR) 1 of 23 (4.3%) died
spontaneously; in Group III (WD) 3 of 26 (11.5%) died or were
euthanized prematurely; in Group IV (HS) 7 of 22 (31.8%) died
or were euthanized prematurely. The spontaneous deaths re-
sulted in the following final numbers of appropriately fixed
brains for histological analysis in each group: Group I (NC) N =
20, Group II (WR) N = 22, Group III (WD) N = 24, and Group
IV (HS) N = 21. All further analysis was restricted to this final
study group for whom acceptable neuropathological data was
available. Plasma [NaJ at the time of euthanasia were statis-
tically equivalent in all three of the corrected groups: Group II
(WR) plasma [NaJ 143 1 mmol/liter; Group III (WD)
plasma [Nat] = 145 1 mmol/liter; Group IV (HS) plasma[Na] = 145 2 mmol/liter.
The correction rates averaged over the first 48 hours from the
start of the correction were greater in the Group III (WD) than
the Group II (WR) rats (P < 0.01), but were equivalent between
each of these two groups and the Group IV (HS) rats. The
correction rates averaged over the first 24 hours from the start
of correction were equivalent in the Group III (WD) and Group
IV (HS) rats, but for both of these groups were significantly
higher than in the Group II (WR) rats (P < 0.01). However,
when maximal correction rates (defined for this study as the
largest increase in plasma [Na1 averaged over any 4 hr period
during the correction) were calculated, they reflected large
differences in correction rates across all of the three correction
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Time from start of correction, hours
Fig. 1. Plasma Na concentrations measured sequentially during the
first 48 hours of correction of hyponatremia for each of the three
treatment groups. The incremental increases in plasma [NaI were
measured at the time points indicated for each of the three treatment
groups undergoing correction of hyponatremia (—A—, Group II, water
restriction; --0--, Group III, water diuresis; i, Group IV, hypertonic
saline). Results are shown as means SE at each time point.
groups (P < 0.01 between each group; Table 1). These marked
differences in maximal rates of correction can also be appreci-
ated graphically in Figure 1 by comparing the slopes of the lines
depicting the increases in plasma [Na] over the first 8 hours of
the corrections for each group.
Table 1 also shows a summary of the results of the neuro-
pathological analysis of the rat brains. As with previous studies
of demyelination following correction of hyponatremia in rats
[11, 13, 15, 16], demyelinative lesions were found predomi-
nantly in multiple regions of the forebrain rather than in the
brainstem, and in this study particularly in the thalamus and
anterior commissure. Demyelinative lesions were found with
increasing frequency across the four study groups: Group I
(NC) = 0%; Group II (WR) = 5%; Group III (WD) = 20%; and
Group IV (HS) = 90%. In addition, the proportion of rats
bearing diffuse (neuropathological score 2) versus focal
(neuropathological score = 1) demyelinative lesions similarly
increased from Groups II through IV.
Table 2 shows the correlation coefficients calculated between
the neuropathological scores and the various parameters that
were monitored during the course of the corrections. The
presence of demyelinative lesions was weakly, but significantly,
inversely correlated with the starting plasma [Na11 (r = —0.31).
The total magnitude of the change in plasma [Na] was also
r P
Starting plasma [Na] —0.31 <0.05
Total change in plasma [NaI
0 to 24 hr 0.41 <0.001
0 to 48 hr 0.32 <0.01
0 to end of correction 0.27 <0.05
Correction rate:
Maximum 4 hr 0.68 <0.001
H20 intake/24 hr prior to
euthanasia —0.65 <0.001
Weight change
following correction —0.68 <0.001
Table 3. Re!
neuropatho
ation between presence of neurological findings (left) and
logical scores in individual rats following correction of
hyponatremia ( = 22.82; P < 0.0001)
Neuropathology score
0 1 2
Absent 41 9 7 57
Present 1 1 8 10
42 10 15 67
weakly correlated with the neuropathological score (r = 0.27),
as were the increases in plasma [Na] over the first 24 and 48
hours of the correction (r = 0.41 and 0.32, respectively).
However, the calculated correlation was greatest with the
maximal rate of correction over any four hour period as defined
above (r = 0.68). The increases in plasma [Nat] over the first 24
and 48 hours were also significantly intercorrelated with the
maximal rate of correction (r = 0.49 and 0.33, respectively,
both P's < 0.01), as expected from the design of the experi-
ments (that is, rats with more rapid rates of correction were
generally those who also experienced larger magnitudes of
correction).
Analysis of neurological findings following correction of
hyponatremia in individual rats showed a significant relation
between the presence of any findings (hyperirritability, poor
grooming, motor deficits, seizure activity, and unresponsive-
ness) and their subsequent neuropathological score (Table 3, P
<0.0001 by chi-square analysis). These findings were clearly a
result of the correction since none of the uncorrected rats
manifested any of these findings, as has been reported previ-
ously in rats maintained chronically hyponatremic using this
protocol [17]. Furthermore, all rats with neurological findings
initially appeared quite normal immediately following the cor-
rection, and their first manifestation of any sign of abnormality
did not occur until 2.2 0.3 days after correction. Although
90% of rats with neurological findings were found to have
demyelinative lesions (including all of the rats whose symptom-
atology was severe enough to warrant premature euthanasia), a
lack of findings was not nearly as good a predictor of the
absence of such lesions since 28% of asymptomatic rats were
also found to have evidence of demyelination (Table 3). High
Table 2. Correlations between neuropathological scores and
correction parameters
L
0
E
E
z
E
Cs0
140
130
120
110
I I I I
0 8 16 24 32 40 48
+15
0
+10
0
C-)
a +50
o 0
0
a)0)C
2-100
)15
a)
a)
a)
2 48
15 67 E
E
Ca
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Fig. 2. Relation between water and food ingestion and the incidence of demyelinative lesions following correction of hyponatremia. A. Mean
water intake of rats for the 24 hr period preceding euthanasia. Rats with no demyelinative lesions (pathology score = 0) had an average daily water
intake of 40 3 ml, as compared to 31 5 ml in rats with focal lesions (pathology score = I) and 6 2 ml in rats with diffuse lesions (pathology
score = 2). B. Mean changes in body weights over the 6 to 7 day period following correction of the hyponatremia expressed as a percent of weight
at the start of the correction. Rats with no demyelinative lesions gained 7.7 1.9% over this period, as compared to 2.4 4.8% in rats with focal
lesions. Rats with diffuse lesions lost 18.8 2.1% over this period. Results are shown as means SE for each group; ** P < 0.01 compared to
rats with pathology score = 0.
Table 4. Relation between weight change (left) and neuropathological
scores in individual rats following correction of hyponatremia
_____
(x2 = 43.90; P < 0.0001)
__________
Neuropathology score
0 1
10.0
 -15%
—ito —14%
 0%
0
2
42
8
10
28.0
6.0
4.0
2.0
0
0
2 2
2
0 12 2
02222
0 2
8 000200 Ol000 0
O 00200 R
ü o o90. 00°
no
inverse correlations were also found between the neuropath-
ological score and ingestive behaviors, specifically water intake
over the 24 hour period prior to euthanasia and the total weight
change following correction (r = —0.65 and —0.68, respec-
tively, Table 2). Figure 2 shows the mean values of these
parameters as a function of the neuropathological score, and
Table 4 shows that the weight changes also were significantly
related to the subsequent neuropathology in individual rats (P <
0.0001 by chi-square analysis). Although small degrees of
weight loss were not predictive of demyelinative lesions, larger
degrees of weight loss (s15%) were 92% predictive of more
diffuse degrees of demyelination. Similar to the absence of
neurological findings, weight gain generally predicted the ab-
sence of neuropathology, but 21% of rats with weight gain
following correction still were found to have demyelinative
lesions, although in most cases these were focal (neuropathol-
ogy score = 1) rather than diffuse in nature (neuropathology
score = 2).
I I
0 10 20 30 40 50
Magnitude of plasma [Na1 correction
in the first 24 hr. mmol/I/ter
Fig. 3. Incidence of demyelinative lesions in individual rats as a
function of both the maximal rate of correction of hyponatremia and
the magnitude of the increase in plasma Na concentration over the
first 24 hours of the correction. Each rat in one of the three correction
groups (water restriction, water diuresis, and hypertonic saline) is
plotted as a function of the maximal rate of increase in plasma [Na]
achieved over any 4 hour period during the correction (abscissa) and the
total magnitude of the increase in plasma [Na] achieved during the first
24 hours of the correction (ordinate). Rats are depicted by their
neuropathology score (0 = no demyelinative lesions; 1 = focal demy-
elinative lesions; 2 = diffuse demyelinative lesions).
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To investigate the possible relation between the correction
parameters and the incidence of demyelination in individual
rats, the neuropathological score of each rat was plotted as a
function of both the maximal rate of correction and the increase
in plasma [Nai over the first 24 hours of correction (Fig. 3).
These two correction parameters were chosen because they
were found to be most highly correlated with the presence of
demyelinative lesions in the corrected rats (Table 2). Animals
bearing focal and diffuse neuropathological lesions had in
common either high maximal correction rates and/or high
24-hour correction magnitudes. Analysis of the 24-hour correc-
tion magnitude alone indicated an absolute threshold for pro-
ducing demyclinative lesions of 16 mmol/liter; no animals
corrected by an amount less than this at 24 hours developed
demyelination, in comparison to a 42% incidence of demyeli-
nation in rats corrected at 24 hours by amounts equal to or
greater than this. Similarly, analysis of the maximum correction
rate alone indicated an absolute threshold for producing demy-
elinative lesions of 1.75 mmol/liter hr; no animals corrected at
a maximal rate less than this developed demyelination, in
comparison to a 54% incidence of demyelination in rats cor-
rected at maximal rates equal to or greater than this. However,
inspection of Figure 3 shows that the rats who developed
demyelinative lesions at the lower 24-hour correction magni-
tudes all had relatively high maximum correction rates, and
similarly the rats who developed demyelinative lesions at lower
maximal correction rates all had relatively high 24-hour correc-
tion magnitudes. Consequently, the same analysis was done
using both of these parameters together, and this revealed that
no rat developed demyelinative changes in whom both of two
conditions were met: the maximal rate of correction of plasma
[Nat] was 4 mmol/liter hr, and the magnitude of correction
of plasma [Na] in the first 24 hours was 25 mmol/liter. In
contrast, for all rats who exceeded either one of these two limits
the incidence of demyelinative lesions was 64%.
Application of discriminant function analysis to these results
(combining the rats with focal and diffuse lesions into a single
demyelination group) showed that use of the maximum rate of
correction correctly predicted the occurrence of demyelination
in 58 of 67 rats (87%), while use of the magnitude of correction
in the first 24 hours correctly predicted the occurrence of
demyelination in 44 of 67 rats (67%). Nonetheless, it should be
noted that a number of rats survived fairly rapid and relatively
large corrections without subsequently developing brain demy-
elinative lesions (Fig. 3).
Discussion
The data presented in this paper is consistent with the results
of multiple previous experimental studies demonstrating that
correction of hyponatremia is associated with the development
of neurological dysfunction and brain myelinolysis in animals
[11—16]. Although this phenomenon is now generally accepted,
our results extend the existing data base in this area because of
the methodology utilized in our studies, which differs signifi-
cantly from previous studies in this area in a number of aspects.
In contrast to previous studies which employed relatively
short periods of acute hyponatremia, our studies focused on
animals with chronic long-standing hyponatremia. Because
both clinical [4] and animal [14, 201 studies have suggested that
ysis following subsequent correction, this model should have
maximally enhanced sensitivity for detecting demyelination in
response to changes in plasma [Na]. An additional advantage
is that rats adapted to chronic hyponatremia using this model
experience virtually no mortality, and little observable morbid-
ity, despite long periods of severe hyponatremia [17]. Thus,
unlike the high mortality rates even before correction of hy-
ponatremia characteristic of many [12—14, 16], though not all
[11, 15], previous studies, using this model it is clear that the
functional neurological deficits following correction of the hy-
ponatremia were causally related to the correction, rather than
a result of the preceding hyponatremia itself. The most likely
reason for both of these differences is the brain volume regula-
tion that occurs over time in response to the hyponatremia.
Previous studies using this model have shown that after three
weeks of chronic hyponatremia brain water contents com-
pletely return to normonatremic levels [171. This absence of
residual brain edema undoubtedly contributes to the low mor-
tality and morbidity which is characteristic of the chronically
hyponatremic rats. However, previous studies in rats have also
demonstrated that brains of hyponatremic rats lose more water
following increases in plasma osmolality than do brains of
normonatremic rats [7, 18]. Thus, the same volume regulatory
adaptation that allows animals to survive in the face of severe
hyponatremia in some ways becomes maladaptive when the
hyponatremia is corrected, by putting animals at risk for greater
potential degrees of osmotic brain dehydration. Although a
causal relation between osmotic dehydration and myelinolysis
following correction of hyponatremia remains to be proven, it
seems likely that this factor contributes in some way to the
neuropathological abnormalities found [3, 15, 181.
Perhaps most importantly, our studies employed carefully
monitored corrections of hyponatremia using methods analo-
gous to those encountered clinically. Particularly worrisome in
this regard has been the frequent use of intraperitoneal injec-
tions of hypertonic saline to correct hyponatremia in rats [11,
13, 15, 16]. This method leads to rapid increases in plasma
[Nai due to prompt re-equilibration of the administered fluid
throughout the extracellular space [21]. Such rapid increases in
plasma [Na] so greatly exceed the rates with which hypona-
tremia is corrected clinically that their relevance to human
disease is debatable. Although several previous studies have
also employed methods of correction similar to ours based upon
water restriction [111, infusion of hypertonic saline [121, and
water diuresis [15], the absence of frequent monitoring of
plasma [NaI during the corrections in these studies precluded
a careful analysis of the relation between the maximal rate of
the correction and the production of brain myelinolysis. Fre-
quent monitoring of plasma [NaJ allowed us to perform a more
rigorous analysis of the relation between the various parameters
characterizing the correction and the subsequent development
of neuropathological changes. Figure 1 and Table 1 graphically
illustrate the problem of calculating correction rates by averag-
ing the starting and ending plasma [Na] over prolonged
periods. The averaged 48-hour correction rates of all three
treatment groups were virtually identical, and bore little rela-
tion to the neuropathology produced. Only correction rates that
accurately reflected the more acute changes occurring during
the first 24 hours of the correction were strongly correlated with
chronicity of hyponatremia increases the risk of brain myelinol- the subsequent development of demyelinative lesions (Table 2).
1280 Verbalis and Martinez: Correction of chronic hyponarremia
In view of the above considerations, several conclusions can
be drawn from our results. First, it is clear that severe hypona-
tremia by itself does not lead to the demyelinative changes
characteristic of pontine and extrapontine myelinolysis. These
findings are in agreement with several other studies that have
examined this issue [13, 15]. However, because previous stud-
ies utilized shorter periods of hyponatremia, the possibility still
existed that more chronic durations of sustained hyponatremia
might cause such changes. The absence of any demyelinative
changes in the brains of rats that were maintained hyponatremic
for four weeks in this study now definitively eliminates this
possibility as well.
Second, the analysis shown in Figure 3 strongly suggests that
both the rate and magnitude of correction are important factors
involved with the development of brain myelinolysis. Brain
pathology clearly occurred in many rats that had high rates of
correction but relatively small magnitudes of correction in the
first 24 hours, and conversely demyelination was found in a few
rats whose maximal rate of correction was relatively low but
whose magnitude of correction in the first 24 hours was large.
The maximal correction rate associated with demyelination in
experimental animals has never been carefully defined previ-
ously, and in these studies it is particularly noteworthy that this
factor represented the single best predictor of subsequent
development of demyelination. Myelinolysis was first observed
in rats whose maximal rate of correction exceeded 1.75 mmol/
liter hr, and the incidence of demyelination increased progres-
sively with more rapid rates of correction. However, at lower
24-hour magnitudes of correction (s25 mmol/liter) the thresh-
old for producing myelinolysis appeared to be closer to 4
mmollliter' hr (Fig. 3). The 24 hour magnitude of correction
associated with demyelination in these studies is similar to
results reported in several earlier studies. Myelinolysis was first
observed in rats whose 24 hour magnitude of correction ex-
ceeded 16 mmol/liter, a value analogous to that suggested in
previous studies of rats [20] and dogs [12]. However, at lower
maximal correction rates (4 mmol/liter hr) the threshold for
producing myelinolysis appeared to be closer to a 24 hour
magnitude of 25 mmol/liter (Fig. 3), a value very similar to that
suggested by more recent studies in rats [161 (although some
concerns have been raised about the methodology used in this
previous study [22]).
Although the incidence of demyelination was 64% in those
rats whose maximal correction rate exceeded 4 mmol/liter hr
or whose total magnitude of correction in the first 24 hours
exceeded 25 mmol/liter, it is striking that not all such rats
developed myelinolysis. The absence of demyelination in some
rats that experienced just as rapid and as large corrections as
rats that developed diffuse myelinolysis indicates that a rapid
and/or large correction of hyponatremia represents a very
significant risk factor for the development of neuropathological
changes, but does not obligatorily lead to such changes in all
cases. Nonetheless, Figure 3 indicates that the degree of risk
increases as both of these parameters increase, and is especially
pronounced when high maximal rates and large 24 hour magni-
tudes are both present.
As with any experimental study, many potential qualifica-
tions of the above conclusions must be taken into account and
alternative interpretations considered. The first issue is the
degree to which the demyelinative lesions observed were
related to functional neurological deficits. Although our data
only demonstrate associations and cannot prove a causal rela-
tion between these effects, the strong association between a
variety of neurological findings, including impaired ingestive
behaviors, and the presence of brain demyelinative lesions (Fig.
2, Tables 2 to 4) strongly supports the functional significance of
the brain pathology produced. These results also indicate that
such impairments in ingestive behaviors represent an easily
quantifiable indicator of the likely presence of diffuse myelinol-
ysis following correction of hyponatremia in rats for future
studies. Nonetheless, the presence of demyelinative lesions in a
large portion of totally asymptomatic rats emphasizes that the
absence of overt neurological symptoms cannot be interpreted
as indicative of an absence of brain damage following correc-
tion; perhaps finer functional testing might have uncovered
more subtle neurological deficits in these animals.
A second potential qualification is that these studies address
chronic hyponatremia rather than acute hyponatremia, and the
latter situation appears to be less prone to the development of
brain myelinolysis following correction of the hyponatremia [4,
8, 14, 21]. Because of this, it has been argued that chronic
asymptomatic hyponatremia is not an ideal, or possibly even
appropriate, model in which to study the neurological and
neuropathological sequelae of correction of hyponatremia [16]
since clinically asymptomatic hyponatremic patients do not
require as prompt a correction [13]. Although this argument has
obvious validity, the advantage of using a model of chronic
asymptomatic hyponatremia is that this should represent the
worst possible case for the development of demyelinative
lesions following correction of the hyponatremia. Because
clinically it is often uncertain what the duration of hypona-
tremia has been in any specific patient, and because many
potential early hyponatremic symptoms are relatively nonspe-
cific (for example, nausea, headache, and confusion), the dis-
tinction between acutely symptomatic and chronically asymp-
tomatic hyponatremic patients is not always as clear as would
be desirable. Consequently, any correction parameters found to
be safe in chronic asymptomatic hyponatremia should in turn be
safe for correcting hyponatremia of any duration, even for those
cases in which the actual duration is not known. Nonetheless, it
must be acknowledged that several previous studies have
clearly shown that animals with acute hyponatremia of shorter
durations can easily tolerate more rapid corrections with less
morbidity and mortality than found using this model of chronic
hyponatremia [15, 20].
A third potential qualification relates to the severity of the
preexisting hyponatremia prior to correction. Animals in this
study were severely hyponatremic (plasma [Nai = 112 1
mmol/Iiter), but obviously lower plasma [Nat] levels have been
achieved in both patients and experimental animal studies.
Most clinical cases of myelinolysis have in fact been reported in
patients with plasma [Na levels 105 mmol/liter prior to
correction 14, 231. Whether the thresholds described here would
also be true of rats with more severe degrees of chronic
hyponatremia is unknown, but since brain electrolyte losses
appear to be proportional to the degree of hyponatremia in-
duced, presumably more severely hyponatremic animals would
experience greater degrees of osmotic dehydration following
equivalent corrections of their hyponatremia. Whether this
would in turn result in the production of brain myelinolysis at
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even lower maximal rates and 24 hour magnitudes of correction
remains to be evaluated by future studies.
Several final qualifications address specific aspects of the
methodology employed in these studies. The protocol used to
induce and maintain chronic hyponatremia in these studies
utilized DDAVP rather than AVP, which is of course the
physiological antidiuretic hormone. Although AVP works
equally well in this experimental paradigm [19], DDAVP was
used because it is a selective V2 receptor agonist and its use
therefore avoids potential confounding vascular and hepatic
effects associated with AVP infusions. Since clinical hypona-
tremic states, including most cases of the syndrome of inappro-
priate antidiuresis, are generally associated with plasma AVP
levels below the threshold for significant vasopressor effects
[24], the use of DDAVP in animal models is advantageous since
it enables the achievement of sufficient degrees of antidiuresis
to maintain severe hyponatremia but without any risk of pro-
ducing unwanted vascular effects. Higher infusion rates of AVP
also frequently cause catabolism and weight loss, which may
represent a contributory factor to the higher mortality rates
observed in some previous hyponatremic models [12—14, 161 as
compared to the very low morbidity and mortality observed in
this model [17]. Nonetheless, the use of DDAVP rather than
AVP must be acknowledged as a potentially significant differ-
ence between this model and human pathophysiology.
Another important methodological consideration concerns
the use of different correction methods to achieve the varied
correction rates and magnitudes shown in Figures 1 and 3.
Although most of the demyelination occurred in the rats who
had much higher maximal rates of correction, because most of
these rats were corrected with hypertonic saline infusions, it
remains possible that the method of correction in some ways
also contributed to the observed neuropathological sequelae.
Hypertonic saline infusion produces a volume expansion, in
contrast to the volume contraction produced in the rats cor-
rected by water diuresis and water restriction. This further
induced hypervolemia in animals who are already volume-
expanded by retained water [25] could conceivably either
worsen, or ameliorate, brain osmotic dehydration in response
to the increased ECF osmolality through a variety of possible
mechanisms such as systemic hypertension, interstitial edema,
or altered vascular resistance. Neither previous studies nor the
present results enable a critical evaluation of this possibility,
and future studies comparing demyelination in groups of ani-
mals that achieve a spectrum of different maximal correction
rates and magnitudes using the same correction methods will be
necessary to address this question. Until such studies are done,
however, the most likely explanation for the high rate of
myelinolysis in the rats corrected with hypertonic saline re-
mains the very rapid rate of rise of plasma [Nat] which was
purposely induced in this group.
Finally, although our results strongly suggest that both the
rate and magnitude of correction are important risk factors for
the development of brain myelinolysis in chronically hypona-
tremic rats, it should be recognized that this conclusion is based
on a retrospective analysis of the results. The actual design of
the study involved using different methods of correction to
produce a spectrum of different correction rates. Although a
spectrum of different correction magnitudes also was produced,
in these studies the maximal rate and magnitude of increases in
plasma [Na] were intercorrelated to the extent that approxi-
mately 25% of the variance of each of these two parameters
could be explained by changes in the other. Consequently,
future studies in which the magnitudes of increases in plasma
[Na11 are varied independently of changes in the rate of
increase will be necessary to definitively address the indepen-
dent contribution of the absolute magnitude of correction of
plasma [Na ] to brain myelinolysis in experimental hypona-
tremia.
Because these studies were done in an effort to better
understand the factors associated with the development of
pontine and extrapontine myelinolysis in human patients, it is
appropriate to attempt to place our results into a clinical
perspective, as has been done in many previous reports of
experimental studies [11—16]. However, it would obviously be
inappropriate to suggest that the limits described for safely
correcting hyponatremia in rats or any other species apply to
humans as well, in either this or other experimental studies. The
clinical relevance of these studies does not lie in the numerical
findings, but rather in the clear demonstration that it is possible
to ascertain safe limits for both the rate and magnitude of
correction of hyponatremia that eliminate, or at least minimize,
the risk of precipitating brain myelinolysis. The exact values for
these limits in human patients can only be ascertained by
clinical studies, many of which have already been done and
describe correction limits not dissimilar to those found in these
experimental studies [3—5, 8, 26, 271.
An additional important implication of these studies is that
they demonstrate the similarity of experimental studies in
hyponatremic animals to human disease in hyponatremic pa-
tients. Our data would suggest that the high incidence of brain
demyelination in some earlier animal studies, and particularly
those employing intraperitoneal injections of hypertonic saline,
might be in part due to the inadvertent production of very rapid
correction rates. When these rates were carefully monitored,
corrections in experimental animals that remained within
ranges usually accomplished in clinical settings were not often
accompanied by brain myelinolysis, whereas those that far
exceeded typical clinical ranges frequently were associated
with adverse neurological findings and brain myelinolysis.
Thus, we would suggest that the relative rarity of reports of this
disorder in human patients is not really a reflection of basic
differences between human and animal physiology, but rather is
indicative of a similarity across species provided that experi-
mental studies are done in a way that more closely resembles
human disease and therapy.
In summary, we evaluated the incidence of neurological and
neuropathological findings following correction of hypona-
tremia at different rates in chronically hyponatremic rats. Brain
myelinolysis was first observed in animals whose maximal (4 hr)
rate of correction exceeded 1.75 mmol/liter hr, and the
incidence of demyelination increased progressively with more
rapid rates of correction. The occurrence of myelinolysis was
found to be related to the magnitude of correction as well, and
was first observed in rats whose absolute increase in plasma
INa1 at 24 hours exceeded 16 mmollliter and also increased
greater following larger 24 hour magnitudes of correction.
However, analysis of the incidence of myelinolysis using both
of these correction parameters together indicated that demyeli-
nation did not occur in rats whose maximal rate of increase in
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plasma fNaJ did not exceed 4 mmol/liter - hr and whose
absolute increase in plasma [Nai did not exceed 25 mmol/liter
in the first 24 hours; for all rats who exceeded either one of
these two limits the incidence of demyelinative lesions was
64%. Our studies therefore suggest that both the rate and the
magnitude of correction of hyponatremia are important varia-
bles in producing myelinolysis in experimental hyponatremia.
However, additional studies in which each of these two related
factors are varied independently of the other will be necessary
to determine more precisely how "rate" and "magnitude"
interact to increase the risk of brain myelinolysis.
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